RPTX stock

Repare Therapeutics Inc (RPTX) financials · $61.8M cap

Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT

Repare Therapeutics Inc (RPTX) $61.8M cap.

Cached annual income statement
LineFY2024FY2023
Operating Income-$93.5M-$116.2M
Net Income-$84.7M-$93.8M
Cached annual balance sheet
LineFY2024FY2023
Total Assets$176.5M$253.9M
Current Assets$171.1M$243.7M
Cash & Equivalents$84.7M$111.3M
PP&E$2.29M$4.21M
Total Liabilities$25.4M$41.8M
Current Liabilities$25.3M$39.1M
Shareholders' Equity$151.1M$212.1M
Retained Earnings-$417.8M-$333.1M
Cached annual cash flow
LineFY2024FY2023
Operating Cash Flow-$76.4M-$127.2M
CapExN/A$1.94M
Investing Cash Flow$49.5M$78.0M
Financing Cash Flow$542.0K$842.0K
Net Change in Cash-$26.6M-$48.3M
Free Cash Flow-$76.4M-$129.1M
These statements as JSON? API free 100/day

FAQ

What is RPTX P/E and revenue?

Repare Therapeutics Inc (RPTX) $61.8M cap.

What is RPTX revenue?

RPTX income-statement cache has no revenue figure yet.

Is RPTX profitable?

Repare Therapeutics Inc last cached net income is -$84.7M (FY2024).

What are RPTX total assets?

Repare Therapeutics Inc last cached total assets are $176.5M (FY2024).

What is RPTX free cash flow?

Repare Therapeutics Inc last cached free cash flow is -$76.4M (FY2024).

Not investment advice. Cached statements, not a live tape.